Is it possible to prevent respiratory pathology?
https://doi.org/10.21518/2079-701X-2020-18-163-170
Abstract
Acute respiratory infections are the most common reason to consult a paediatrician. Children, especially during critical periods of immune response, are one of the most vulnerable groups to infections. The prevention of recurring respiratory infections is very important, especially from the beginning of attending pre-school and school facilities. Since ancient times, preventive measures such as rational daily routine, sufficient physical activity, correction of nutritional status, phytotherapy and homeopathic treatment have been used. In recent years these children have been optimising their vitamin D status and taking antioxidant vitamins, micro- and macronutrients. To date, as a result of innovative research on the human microbiome, information has emerged on its impact on the human body as a whole. The connection of the intestinal microbiota with the brain (gut-brain axis), with the respiratory tract (gut-lung axis), the cardiovascular system, kidneys and even mental health has been proved. The use of multistrain and multispecies probiotics in the prevention of recurrent infections in children opens up new opportunities to influence the child’s immune response and to form food tolerance. Today, a new multistrain multispecies probiotic (manufacturer ADM Protexin, UK) for the prevention of recurrent respiratory infections in children has appeared on the market. Studies have shown that using several strains of lactobacillus contained in this probiotic leads to more consistent results than monostrains and placebo in the prevention of respiratory diseases.
Given the problem of antibiotic resistance, especially in young children, the new possibilities of preventing acute respiratory diseases in children using multistrain and multispecies probiotics make it possible not only to reduce the number and severity of episodes of acute respiratory infections, but also to reduce the frequency of antibiotic use.
Given the problem of antibiotic resistance, especially in young children, the new possibilities of preventing acute respiratory diseases in children using multistrain and multispecies probiotics make it possible not only to reduce the number and severity of episodes of acute respiratory infections, but also to reduce the frequency of antibiotic use.
About the Authors
I. N. Zakharova
Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Dr. of Sci. (Med.), Professor, Honoured Doctor of the Russian Federation, Head of the Department of Pediatrics named after G.N. Speransky
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993, Russia
I. V. Berezhnaya
Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Cand. of Sci. (Med.), Associate Professor of the Department of Pediatrics named after G.N. Speransky
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993, Russia
References
1. Zakharova I.N., Osmanov I.M., Goryainova A.N., Gavelya N.V., Ruchkina E.V. Modern etiological and clinical features of acute respiratory viral infection in children. Are there any prerequisites for antiviral therapy? Literature review. Farmateka = Pharmateca. 2020;(1):14–19. (In Russ.) doi: 10.18565/pharmateca.2020.1.14-19.
2. Sullivan M., Hallam S.J., Woyke T., Sullivan M.B. Viral dark matter and virushost interactions resolved from publicly available microbial genomes. eLife. 2015;4:e08490. doi: 10.7554/eLife.08490.
3. Malesker M.A., Callahan-Lyon P., Ireland B., Irwin R.S. Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Chest. 2017;152(5):1021–1037. doi: 10.1016/j.chest.2017.08.009.
4. Wishaupt J., van der Ploeg T., de Groot R., Versteegh F.G.A., Hartwig N.G. Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen. BMC Infect Dis. 2017;17:62. doi: 10.1186/s12879-016-2118-6.
5. Appak Ö., Duman M., Belet N., Sayiner A.A. Viral respiratory infections diagnosed by multiplex polymerase chain reaction in pediatric patients. J Med Virol. 2019;91(5):731–737. doi: 10.1002/jmv.25379.
6. Martínez-Roig A., Salvadó M., Caballero-Rabasco M.A., Sánchez-Buenavidaa A., López-Seguraa N., Bonet-Alcainaa M. Viral coinfection in childhood respiratory tract infections. Arch Bronconeumol. 2015;51(1):5–9. doi: 10.1016/j.arbres.2014.01.018.
7. Fillatre A., François C., Segard C., Duverlie G., Hecquet D., Pannier C. et al. Epidemiology and seasonality of acute respiratory infections in hospitalized children over four consecutive years (2012–2016). J Clin Virol. 2018;102:27–31. doi: 10.1016/j.jcv.2018.02.010.
8. Ghazaly M., Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr. 2018;177(6):913–920. doi: 10.1007/s00431-018-3138-6.
9. Jain S., Williams D.J., Arnold S.R., Ampofo K., Bramley A.M. et al. Communityacquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. doi: 10.1056/NEJMoa1405870.
10. Yu C., Fedoric B., Anderson P.H., Lopez A.F., Grimbaldeston M.A. Vitamin D3 signalling to mast cells: A new regulatory axis. Int J Biochem Cell Biol. 2011;43(1):41–46. doi: 10.1016/j.biocel.2010.10.011.
11. Vassallo M.F., Camargo C.A.Jr. Potential mechanisms for the hypothesized link between sunshine, vitamin D and food allergy in children. J Allergy Clin Immunol. 2010;126(2):217–222. Available at: https://www.jacionline.org/article/S0091-6749(10)00968-1/pdf.
12. Abuzeid W.M., Akbar N.A., Zacharek M.A. Vitamin D and chronic rhinitis. Curr Opin Allergy Clin Immunol. 2012;12(1):13–17. doi: 10.1097/ACI.0b013e32834eccdb.
13. Benson A.A., Toh J.A., Vernon N., Jariwala S.P. The role of vitamin D in the immunopathogenesis of allergic skin diseases. Allergy. 2012;67(3):296–301. doi: 10.1111/j.1398-9995.2011.02755.x.
14. Zakharova I.N., Skorobogatova E.V. Correction of vitamin deficiency in children. RMZH = RMJ. 2006;(1):70–73. (In Russ.)
15. Seypenova A.N., Ismagulova A.U., Savel’cheva I.A. Social-biological factors, сonducing realizacion of acute respiratory infection affected in ill children. Meditsinskiy zhurnal Zapadnogo Kazakhstana = Medical Journal of West Kazakhstan. 2014;(1):12–16. (In Russ.) Available at: https://e.lanbook.com/reader/journalArticle/248074/#1.
16. Artyukhova Yu.K. How to temper your body. Minsk: Nedra; 1999. 54 p. (In Russ.)
17. Quigley E.M.M. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? Nat Rev Gastroenterol Hepatol. 2017;14(5):315–320. doi: 10.1038/nrgastro.2017.29.
18. Li T., Chiang J.Y. Bile acids as metabolic regulators. Curr Opin Gastroenterol. 2015;31(2):159–165. doi: 10.1097/MOG.0000000000000156.
19. Jensen H., Grimmer S., Naterstad K., Axelsson L. In vitro testing of commercial and potential probiotic lactic acid bacteria. Int J Food Microbiol. 2012;153(1–2):216–222. doi: 10.1016/j.ijfoodmicro.2011.11.020.
20. Ouwehand A., Isolauri E., Salminen S. The role of intestinal microflora for development of the immune system in early childhood. Eur J Nutr. 2002;41:132–137. doi: 10.1007/s00394-002-1105-4.
21. Yan F., Polk D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002;277(52):50959–50965. doi: 10.1074/jbc.M207050200.
22. Sugyan N.G., Zakharova I.N. Вac-Set multiprobiotic: results of russian and foreign clinical research. Meditsinskiy sovet = Medical Council. 2017;(19):104–110. (In Russ.) doi: 10.21518/2079-701X-2017-19-104-110.
23. Leyer G.J., Li S., Mubasher M.E., Reifer C., Ouwehand A.C. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009;124(2):e172–179. doi: 10.1542/peds.2008-2666.
24. Smith T.J., Rigassio-Radler D., Denmark R., Haley T., Touger-Decker R. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013;109(11):1999–2007. Available at: https://pubmed.ncbi.nlm.nih.gov/23020819.
Review
For citations:
Zakharova IN, Berezhnaya IV. Is it possible to prevent respiratory pathology? Meditsinskiy sovet = Medical Council. 2020;(18):163-170. (In Russ.) https://doi.org/10.21518/2079-701X-2020-18-163-170
Views:
510
Email this article 